$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Correct Dosage of Cassimerson and Instructions on How to Use it
2026-02-01 22:25:32
Check Details
How effective are dutasteride soft capsules?
2026-02-01 22:25:32
Check Details
Datopotamab price and where to buy
2026-02-01 22:25:32
Check Details
Detailed explanation of EPKINLY (icarelatumumab), bringing new options to lymphoma patients
2026-02-01 22:25:32
Check Details
Possible side effects of using corvalizumab and countermeasures
2026-02-01 22:25:32
Check Details
How effective is Cassimerson's treatment?
2026-02-01 22:25:32
Check Details
Side effects of Elivaldofen gene therapy detailed, key information and precautions
2026-02-01 22:25:32
Check Details
What are the precautions for dutasteride soft capsules?
2026-02-01 22:25:32
Check Details
Introduction and marketing status of datopotamab
2026-02-01 22:25:32
Check Details
Detailed explanation of the usage and dosage of Elivaldofen gene therapy: ensuring efficacy and safety
2026-02-01 22:25:32
Check Details
Ikorituzumab receives FDA approval: new hope for lymphoma patients
2026-02-01 22:25:32
Check Details
Kovalizumab price information and purchasing guide
2026-02-01 22:25:32
Check Details
1
2
...
1401
1402
1403
1404
1405
1406
1407
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
2
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
3
FDA Accelerated Approval of Voceryq: First Plasmid DNA Immunotherapy for Adult Recurrent Respiratory Papillomatosis
4
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
5
Revumenib: Key Considerations Before and During Treatment
6
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
7
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
8
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
9
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
10
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
11
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
12
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits